PARP1 inhibition by Olaparib reduces the lethality of pancreatic cancer cells and increases their sensitivity to Gemcitabine

Quinonero, F; Mesas, C; Munoz-Gamez, JA; Jimenez-Luna, C; Perazzoli, G; Prados, J; Melguizo, C; Ortiz, R

Prados, J (通讯作者)，Univ Granada, Ctr Biomed Res CIBM, Inst Biopathol & Regenerat Med IBIMER, Granada 18100, Spain.

BIOMEDICINE & PHARMACOTHERAPY, 2022; 155 ():

Abstract

Pancreatic cancer (PC) is one of the tumors with the lowest survival rates due to the poor efficacy of the treatments currently used. Gemcitabine (GMZ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索